Quinazoline Based HSP90 Inhibitors: Synthesis, Modeling Study and ADME Calculations Towards Breast Cancer Targeting

This publication has 39 references indexed in Scilit:

• Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
• Synthesis and biological evaluation of 2,4-diaminoquinazoline derivatives as novel heat shock protein 90 inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2011
• Targeting HSP90 for cancer therapy
  British Journal of Cancer, 2009
• Development of thioquinazolinones, allosteric Chk1 kinase inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2009
• New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
  Drug Resistance Updates, 2009
• A novel class of Hsp90 inhibitors isolated by structure-based virtual screening
  Bioorganic & Medicinal Chemistry Letters, 2007
• Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
  Journal of Medicinal Chemistry, 2002
• HSP90 as a new therapeutic target for cancer therapy: the story unfolds
  Expert Opinion on Biological Therapy, 2002
• A New Atom-Additive Method for Calculating Partition Coefficients
  Journal of Chemical Information and Computer Sciences, 1997
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
  Advanced Drug Delivery Reviews, 1997